Macquarie Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-139,544
| Closed | -$7.56M | – | 944 |
|
|
2025
Q3 | $7.56M | Buy |
139,544
+15,900
| +13% | +$909K | 0.01% | 866 |
|
|
2025
Q2 | $6.8M | Buy |
123,644
+5,800
| +5% | +$342K | 0.01% | 903 |
|
|
2025
Q1 | $8.33M | Sell |
117,844
-3,520
| -3% | -$237K | 0.01% | 844 |
|
|
2024
Q4 | $7.98M | Buy |
121,364
+749
| +0.6% | +$50.2K | 0.01% | 852 |
|
|
2024
Q3 | $8.48M | Hold |
120,615
| – | – | 0.01% | 851 |
|
|
2024
Q2 | $9.93M | Buy |
120,615
+2,003
| +2% | +$167K | 0.01% | 817 |
|
|
2024
Q1 | $10.4M | Hold |
118,612
| – | – | 0.01% | 813 |
|
|
2023
Q4 | $11.4M | Sell |
118,612
-11,653
| -9% | -$1.03M | 0.01% | 792 |
|
|
2023
Q3 | $11.5M | Buy |
130,265
+1,146
| +0.9% | +$102K | 0.01% | 753 |
|
|
2023
Q2 | $11.2M | Sell |
129,119
-240
| -0.2% | -$22.6K | 0.01% | 763 |
|
|
2023
Q1 | $12.6M | Hold |
129,359
| – | – | 0.01% | 762 |
|
|
2022
Q4 | $13.4M | Buy |
129,359
+399
| +0.3% | +$37.5K | 0.02% | 777 |
|
|
2022
Q3 | $10.9M | Sell |
128,960
-764
| -0.6% | -$68K | 0.01% | 814 |
|
|
2022
Q2 | $10.7M | Sell |
129,724
-24,040
| -16% | -$1.91M | 0.01% | 849 |
|
|
2022
Q1 | $11.9M | Sell |
153,764
-67,637
| -31% | -$5.66M | 0.01% | 897 |
|
|
2021
Q4 | $19.6M | Sell |
221,401
-3,520
| -2% | -$290K | 0.02% | 755 |
|
|
2021
Q3 | $17.4M | Sell |
224,921
-126
| -0.1% | -$9.94K | 0.01% | 805 |
|
|
2021
Q2 | $18.8M | Buy |
225,047
+1,500
| +0.7% | +$119K | 0.02% | 800 |
|
|
2021
Q1 | $16.9M | Sell |
223,547
-15,524
| -6% | -$1.27M | 0.02% | 582 |
|
|
2020
Q4 | $21M | Sell |
239,071
-2,780
| -1% | -$220K | 0.03% | 504 |
|
|
2020
Q3 | $18.4M | Buy |
241,851
+24,322
| +11% | +$2.46M | 0.03% | 491 |
|
|
2020
Q2 | $26.8M | Buy |
217,529
+889
| +0.4% | +$88.4K | 0.05% | 402 |
|
|
2020
Q1 | $18.3M | Sell |
216,640
-4,900
| -2% | -$422K | 0.04% | 435 |
|
|
2019
Q4 | $18.7M | Sell |
221,540
-1,840
| -0.8% | -$139K | 0.03% | 530 |
|
|
2019
Q3 | $15.1M | Hold |
223,380
| – | – | 0.03% | 516 |
|
|
2019
Q2 | $19.1M | Buy |
223,380
+20,530
| +10% | +$1.76M | 0.03% | 471 |
|
|
2019
Q1 | $18M | Buy |
202,850
+5,790
| +3% | +$537K | 0.03% | 487 |
|
|
2018
Q4 | $16.8M | Sell |
197,060
-4,240
| -2% | -$403K | 0.03% | 470 |
|
|
2018
Q3 | $19.5M | Buy |
201,300
+39,170
| +24% | +$3.91M | 0.03% | 486 |
|
|
2018
Q2 | $15.3M | Buy |
162,130
+160,430
| +9,437% | +$14M | 0.03% | 539 |
|
|
2018
Q1 | $138K | Sell |
1,700
-3,500
| -67% | -$300K | ﹤0.01% | 1809 |
|
|
2017
Q4 | $379K | Sell |
5,200
-35,513
| -87% | -$3.09M | ﹤0.01% | 1528 |
|
|
2017
Q3 | $3.79M | Sell |
40,713
-3,439
| -8% | -$304K | 0.01% | 823 |
|
|
2017
Q2 | $4.01M | Sell |
44,152
-11,231
| -20% | -$1.02M | 0.01% | 804 |
|
|
2017
Q1 | $4.86M | Sell |
55,383
-27,173
| -33% | -$2.42M | 0.01% | 752 |
|
|
2016
Q4 | $6.84M | Sell |
82,556
-39,028
| -32% | -$3.36M | 0.01% | 672 |
|
|
2016
Q3 | $11.2M | Buy |
121,584
+44,127
| +57% | +$4.16M | 0.02% | 571 |
|
|
2016
Q2 | $6.03M | Sell |
77,457
-47,986
| -38% | -$4.08M | 0.01% | 664 |
|
|
2016
Q1 | $10.3M | Buy |
125,443
+67,893
| +118% | +$5.52M | 0.02% | 545 |
|
|
2015
Q4 | $6.03M | Sell |
57,550
-9,400
| -14% | -$982K | 0.01% | 662 |
|
|
2015
Q3 | $7.05M | Sell |
66,950
-12,950
| -16% | -$1.73M | 0.02% | 635 |
|
|
2015
Q2 | $10.9M | Buy |
79,900
+16,400
| +26% | +$2.03M | 0.02% | 513 |
|
|
2015
Q1 | $7.91M | Buy |
63,500
+60,300
| +1,884% | +$6.39M | 0.02% | 610 |
|
|
2014
Q4 | $289K | Hold |
3,200
| – | – | ﹤0.01% | 1357 |
|
|
2014
Q3 | $231K | Sell |
3,200
-10,000
| -76% | -$657K | ﹤0.01% | 1377 |
|
|
2014
Q2 | $821K | Sell |
13,200
-4,500
| -25% | -$272K | ﹤0.01% | 1232 |
|
|
2014
Q1 | $1.21M | Hold |
17,700
| – | – | ﹤0.01% | 1128 |
|
|
2013
Q4 | $1.24M | Sell |
17,700
-16
| -0.1% | -$1.09K | ﹤0.01% | 1111 |
|
|
2013
Q3 | $1.28M | Sell |
17,716
-284
| -2% | -$18.9K | ﹤0.01% | 1098 |
|
|
2013
Q2 | $1M | Buy |
+18,000
| New | +$1.12M | ﹤0.01% | 1155 |
|
Other funds holding BMRN
Macquarie Group's BMRN Position: Q4 2025 in Review
Macquarie Group sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 139,544 shares — an estimated $7.56M sold.
Macquarie Group first reported a position in BMRN in Q2 2013 and held it in 50 quarters. The position peaked at $26.8M in Q2 2020. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.
- Macquarie Group reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 139,544 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $7.56M.
- Macquarie Group first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 50 quarters.
- Macquarie Group's BioMarin Pharmaceuticals position peaked at $26.8M in Q2 2020.
- 539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.